NPI: 1215233986 · MERIDIAN, MS 39301 · Obstetrics & Gynecology Physician · NPI assigned 01/28/2011
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP / CLO) |
| Parent Organization | ANDERSON REGIONAL MEDICAL CENTER |
| NPI Enumeration Date | 01/28/2011 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,059 | $873K |
| 2019 | 18,985 | $814K |
| 2020 | 15,409 | $533K |
| 2021 | 16,022 | $625K |
| 2022 | 15,619 | $562K |
| 2023 | 10,987 | $453K |
| 2024 | 9,176 | $297K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 64635 | 1,459 | 1,298 | $1.19M | |
| 64493 | 1,668 | 1,468 | $646K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14,749 | 13,289 | $546K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,576 | 1,675 | $460K |
| 64483 | 1,301 | 1,208 | $376K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 16,989 | 15,148 | $280K |
| 80305 | 26,295 | 23,198 | $220K | |
| 64490 | 348 | 320 | $140K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1,428 | 1,257 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,639 | 2,220 | $49K |
| 64633 | 40 | 40 | $40K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 911 | 769 | $30K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 336 | 296 | $28K |
| 97597 | 530 | 319 | $27K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 403 | 366 | $15K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 97 | 66 | $14K |
| 62321 | 43 | 40 | $12K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 529 | 503 | $9K |
| 95924 | 37 | 29 | $3K | |
| 11043 | 24 | 14 | $2K | |
| 93923 | 54 | 31 | $2K | |
| 64636 | 1,564 | 1,131 | $1K | |
| 64491 | 333 | 302 | $966.66 | |
| 82570 | 612 | 523 | $961.06 | |
| 95923 | 37 | 29 | $830.63 | |
| 72110 | 13 | 13 | $784.99 | |
| 87070 | 168 | 142 | $650.68 | |
| 81025 | 73 | 66 | $496.50 | |
| 80061 | Lipid panel | 37 | 29 | $443.45 |
| 87186 | 60 | 42 | $408.74 | |
| 87077 | 58 | 42 | $399.92 | |
| 80053 | Comprehensive metabolic panel | 39 | 32 | $377.80 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40 | 33 | $279.54 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 38 | 30 | $273.84 |
| 84443 | Thyroid stimulating hormone (TSH) | 16 | 12 | $234.96 |
| 83036 | Hemoglobin; glycosylated (A1C) | 18 | 15 | $175.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,890 | 5,278 | $167.97 |
| 11045 | 1,435 | 195 | $86.61 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 4,207 | 3,798 | $32.00 |
| A9270 | Non-covered item or service | 786 | 685 | $20.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,145 | 4,503 | $16.46 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 7,672 | 6,535 | $14.20 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 120 | 117 | $10.15 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 134 | 133 | $3.93 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,534 | 893 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 96 | 65 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 122 | 107 | $0.00 |
| 64634 | 40 | 40 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 37 | 27 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 12 | 12 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 1,413 | 1,280 | $0.00 |
| 64494 | 1,519 | 1,292 | $0.00 | |
| 64484 | 1,151 | 1,065 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 231 | 200 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 117 | 107 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 34 | 27 | $0.00 |